TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
DYN

Dyne Therapeutics Inc

Healthcare · Biotechnology

16.00$ -2.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Dyne Therapeutics Inc (DYN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 994 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DYN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
205 165 522 826 769 691 721 729 867 1,187 1,080 994
168 129 488 792 736 659 690 698 806 1,127 1,021 938
130 122 272 608 532 435 472 485 574 893 753 676
158 123 454 779 724 642 677 684 792 1,111 972 898
53 74 44 51 63 61 52 158 175 215 215 292
30 51 22 30 43 42 34 41 60 51 51 78
4.7 4.7 4.8 4.8 4.8 4.9 5.1 5.0 5.0 5.0 5.0 5.4
3.6 23 7.2 1.9 6.2 6.6 7.0 14 12 8.1 11 12
– – – – – – – 99 99 149 149 199
152 91 478 775 706 630 669 571 692 972 865 702
-566 -633 -698 -763 -860 -950 -1,065 -1,176 -1,284 -1,396 -1,517 -1,696
61 61 81 93 101 102 110 114 142 128 165 165

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?